INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 54 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,149,539 | -80.7% | 2,071,242 | -58.6% | 0.01% | -76.3% |
Q3 2022 | $5,950,000 | +88.2% | 5,000,000 | 0.0% | 0.04% | +100.0% |
Q2 2022 | $3,162,000 | -44.5% | 5,000,000 | 0.0% | 0.02% | -26.9% |
Q1 2022 | $5,700,000 | -49.3% | 5,000,000 | 0.0% | 0.03% | -38.1% |
Q4 2021 | $11,250,000 | +31.6% | 5,000,000 | +100.0% | 0.04% | +20.0% |
Q3 2021 | $8,550,000 | – | 2,500,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 6,353,645 | $7,561,000 | 0.31% |
SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $1,756,000 | 0.24% |
EAM Investors, LLC | 840,556 | $1,000,000 | 0.22% |
Gratus Capital, LLC | 1,249,248 | $1,487,000 | 0.16% |
Ally Bridge Group (NY) LLC | 86,242 | $103,000 | 0.07% |
MARINER INDEPENDENT ADVISOR NETWORK, LLC | 1,252,822 | $1,491,000 | 0.06% |
Bleichroeder LP | 250,000 | $298,000 | 0.06% |
GSA CAPITAL PARTNERS LLP | 324,784 | $386,000 | 0.05% |
Polar Capital Holdings Plc | 5,000,000 | $5,950,000 | 0.04% |
PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $649,000 | 0.03% |